SGFG
IMNM icon

Silver Grove Financial Group’s Immunome IMNM Stock Holding History

Silver Grove Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212 Buy
+10
New +$214 ﹤0.01% 2233

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Silver Grove Financial Group's IMNM Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Immunome (IMNM) in Q2 2026: 10 shares worth $212. The stake represents ﹤0.01% of the portfolio and ranks #2233 among its holdings.

202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Silver Grove Financial Group held 10 shares of Immunome worth $212 as of Q2 2026.
  • Immunome was a new Silver Grove Financial Group position in Q2 2026.
  • Immunome made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #2233 holding.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.